TrialRheumatology (Oxford, England)2021

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.

Dennis McGonagle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.